Westwood Holdings Group’s AstraZeneca AZN Stock Holding History

Westwood Holdings Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$559K	Buy	2,985 +447	+18%	+$84.1K	﹤0.01%	428
2026 Q1	$492K	Buy	+2,538	New	+$489K	﹤0.01%	390
2020 Q1	–	Sell	-1,082	Closed	-$108K	–	416
2019 Q4	$108K	Hold	1,082	–	–	﹤0.01%	483
2019 Q3	$96K	Sell	1,082 -527	-33%	-$45.7K	﹤0.01%	445
2019 Q2	$133K	Buy	+1,609	New	+$126K	﹤0.01%	462

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Westwood Holdings Group's AZN Position: Q2 2026 in Review

Westwood Holdings Group increased its AstraZeneca (AZN) stake by 18% in Q2 2026, buying an estimated $84.1K and bringing the position to 2,985 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Westwood Holdings Group first reported a position in AZN in Q2 2019 and has held it in 5 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Westwood Holdings Group held 2,985 shares of AstraZeneca worth $559K as of Q2 2026.
Westwood Holdings Group bought 447 AstraZeneca shares in Q2 2026, an estimated $84.1K.
AstraZeneca made up ﹤0.01% of Westwood Holdings Group's portfolio in Q2 2026, its #428 holding.
Westwood Holdings Group first reported a position in AstraZeneca in Q2 2019 and has held it in 5 quarters since.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Westwood Holdings Group's 13F filing for Q2 2026, filed 14 Aug 2026.